scapulohumeral periarthritis
Conditions
Interventions
experimental group:Ultrasound-guided PRF inactivation of MTrPs
control group:Ultrasound-guided dry needling of MTrPs
Sponsors
Sixth People's Hospital of Nantong
Eligibility
Sex/Gender
All
Age
40 Years to 90 Years
Inclusion criteria
Inclusion criteria: (1) Age = 40 years old, regardless of gender; (2) The symptoms are single/bilateral nontraumatic pain around the shoulder joint, which worsens after the activity, and may wake up at night, accompanied by limited range of motion of the shoulder joint; (3) The duration of the above symptoms is = 9 months; (4) Physical examination revealed the presence of MTrPs in the shoulder muscles; (5) MRI images of the shoulder joint showed fluid accumulation in the sliding bursa and glenohumeral joint cavity of the shoulder, edema and exudation of the muscles around the shoulder, and 0-2 grade rotator cuff injury; The thickness of the axillary joint capsule on oblique coronal T2 weighted images was 3-4 mm.
Exclusion criteria
Exclusion criteria: (1) Have received oral medicine, physiotherapy and other treatments within 3 months; (2) MRI of shoulder joint showed abnormal bone destruction or complete rotator cuff tear, or T2 weighted oblique coronal imaging showed that the thickness of axillary joint capsule was = 4 mm; (3) Congenital disease of shoulder joint, with a history of shoulder surgery; (4) Shoulder joint pain caused by neck diseases or rheumatic immune related diseases, such as cervical spondylosis of nerve root type, gouty arthritis, etc; (5) Primary or secondary bone and soft tissue tumors around the shoulder joint; (6) Inflammation stage of local or systemic infection of shoulder joint, tumor cachexia, coagulation dysfunction, pregnancy, anemia, female menstrual period, etc; (7) Complicated with uncontrolled hypertension, coronary heart disease, diabetes, cerebrovascular disease, digestive tract disease, etc; (8) Those who have contraindicated MRI examination, such as metal implants in the body; (9) Have a history of allergy to lidocaine.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visual Analogue Scale, VAS; | — |
Secondary
| Measure | Time frame |
|---|---|
| Active range of motion,AROM;Constant-Murley Score, CMS;36-item short-from health survey, SF-36; | — |
Countries
China
Contacts
Public ContactShen Wei
Sixth People's Hospital of Nantong
Outcome results
None listed